Bringing you the Best Analytical Legal News
This column will provide all information related to Law Firms.
Lakshmikumaran & Sridharan Attorneys advised NU Hospitals Private Limited on a significant minority investment by Somerset Indus Capital Partners, involving both primary and secondary stake components.
Continue reading
The transaction reflects strategic collaboration in the region’s growing residential real estate market.
Continue reading
Cyril Amarchand Mangaldas advised Vixar on its acquisition of a shareholding in Bloombay Enterprises Private Limited, which operates The Belgian Waffle Co., one of India’s leading dessert-focused QSR brands with over 700 outlets across 250 cities.
Continue reading
The transaction involved the transfer of 100% shareholding through share purchase agreements, marking a key infrastructure asset monetisation deal.
Continue reading
The merger involves equity issuance to Orient shareholders, cancellation of cross-holdings, and regulatory approvals, representing a key consolidation move in India’s cement and infrastructure sector.
Continue reading
The IPO, which saw over 39× subscription, marked a landmark transaction in India’s equity capital markets and commenced trading on the BSE and NSE on 19 December 2025.
Continue reading
The merger involves equity issuance by Ambuja to ACC shareholders and results in a post-merger change in Ambuja’s shareholding structure, marking a significant consolidation in India’s cement sector.
Continue reading
Shardul Amarchand Mangaldas advised Pune IT City Metro Rail Limited on awarding the operations and maintenance contract for Pune Metro Line III to global mobility major Keolis S.A.
Continue reading
Fox & Mandal successfully represented Karan Paul before the Punjab & Haryana High Court in a high-profile arbitration concerning the Punjab Kings IPL franchise. The Court appointed Justice Harinder Singh Sidhu (Retd.) as sole arbitrator to adjudicate the chairmanship dispute in KPH Dream Cricket Private Limited, marking a key procedural milestone in the shareholder dispute.
Continue reading
The transaction, India’s largest disclosed private credit deal in the telecom sector, was structured to support Vodafone Idea Limited’s capital expenditure and business growth.
Continue reading
Shardul Amarchand Mangaldas advised CORONA Remedies Limited and selling shareholders on its ₹655.38 crore IPO, which witnessed exceptional investor demand with over 137x subscription.
Continue reading
Shardul Amarchand Mangaldas advised the Book Running Lead Managers on ICICI Prudential AMC’s ₹10,602 crore IPO, one of India’s largest offerings, listed on BSE and NSE in December 2025.
Continue reading
The transaction was undertaken in compliance with SEBI ICDR Regulations and marks one of the largest rights issues in the Indian capital markets.
Continue reading
Shardul Amarchand Mangaldas advised Nephrocare Health Services Limited (Nephroplus) on its initial public offering aggregating to approximately US$ 95.99 million, covering Indian law, regulatory compliance, and prospectus and listing support.
Continue reading
The transaction involves multidisciplinary legal advice spanning M&A, employment, tax, data privacy, and equity compensation matters.
Continue reading
The transaction resulted in a change of control and triggered a mandatory open offer under SEBI takeover regulations, alongside structured acquisition financing.
Continue reading
The IPO comprised a fresh issue and an offer for sale, with IFC divesting part of its shareholding. Nephrocare’s equity shares were listed on Indian stock exchanges on 17 December 2025.
Continue reading
Shardul Amarchand Mangaldas advised KCC Buildcon Private Limited on the sale of its annuity road assets forming part of the Delhi—Amritsar—Katra Expressway under NHAI’s Hybrid Annuity Model.
Continue reading
Shardul Amarchand Mangaldas advised Attentive.ai Group on its USD 30.5 million Series B funding round led by Insight Partners to scale its AI-driven SaaS platform.
Continue reading
Shardul Amarchand Mangaldas advised Medi Assist Healthcare Services Limited on its INR 198 crore fundraise through a preferential issue to MIT and 238 Plan Associates LLC.
Continue reading